ADNEXUS Trademark

Trademark Overview


On Friday, August 2, 2024, a trademark application was filed for ADNEXUS with the United States Patent and Trademark Office. The USPTO has given the ADNEXUS trademark a serial number of 98680841. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, February 18, 2025. This trademark is owned by ADNEXUS BIOTECHNOLOGIES INC.. The ADNEXUS trademark is filed in the Pharmaceutical Products category with the following description:

Biotechnology and pharmaceutical products for human and animal use for the treatment and prevention of diseases.
adnexus

General Information


Serial Number98680841
Word MarkADNEXUS
Filing DateFriday, August 2, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, February 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiotechnology and pharmaceutical products for human and animal use for the treatment and prevention of diseases.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameADNEXUS BIOTECHNOLOGIES INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHeath, TX 75032

Trademark Events


Event DateEvent Description
Friday, August 2, 2024NEW APPLICATION ENTERED
Tuesday, February 11, 2025ASSIGNED TO EXAMINER
Tuesday, February 18, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 18, 2025NON-FINAL ACTION E-MAILED
Tuesday, February 18, 2025NON-FINAL ACTION WRITTEN
Saturday, December 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED